Ra Capital Management, L.P. Aadi Bioscience, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.03 - $14.22 $2.49 Million - $2.95 Million	207,190 Added 54.09%	590,218 $8.34 Million
Q2 2022 Aug 15, 2022	BUY	$11.57 - $17.92 $4.43 Million - $6.86 Million	383,028 New	383,028 $4.72 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $29.02 $6.72 Million - $10.1 Million	-347,668 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.52 - $41.85 $8.87 Million - $14.5 Million	347,668 New	347,668 $10.2 Million

13.7M

4.9K

700

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $27.7M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.